Kymera Therapeutics reported cash from operations of -$54.06M and free cash flow of -$51.90M for the quarter ended Jun 2026, up 9.7% year over year. This cash flow statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||
| Net Income | -28.71M | -34.05M | -36.97M | -40.85M | -44.92M | -38.69M | -45.38M | -43.43M | -57.55M | -19.36M | -57.90M | -50.99M | -72.18M | -80.81M | -74.50M | -84.67M | -92.62M | -97.99M | -84.22M | -75.69M | ||||||||
| Share-based CompensationStock Comp. | 7.40M | 8.68M | 7.87M | 9.62M | 9.08M | 8.91M | 48.83M | 11.18M | 11.65M | 11.97M | 14.34M | 14.90M | 13.80M | 14.23M | 15.41M | 15.80M | 14.45M | 16.01M | 18.94M | |||||||||
| Asset Writedowns and ImpairmentWritedown | 4.92M | 3.85M | 0.04M | |||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -37.26M | -38.35M | -40.30M | -38.98M | -34.27M | -39.54M | -43.97M | -35.26M | -31.65M | 8.04M | -39.59M | -42.94M | -50.19M | -61.78M | -79.15M | -59.88M | -27.11M | -66.75M | -88.84M | -54.06M | ||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 1.66M | 1.64M | 1.18M | 0.68M | -0.06M | -0.91M | -1.33M | -1.42M | -1.22M | -1.27M | -3.07M | -4.02M | -3.62M | -3.27M | -2.52M | -2.12M | -2.19M | -2.04M | -2.73M | -2.33M | ||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.67M | 0.69M | 0.69M | 0.70M | 0.77M | 0.82M | 0.88M | 0.90M | 0.90M | 0.89M | 1.46M | 1.94M | 1.99M | 1.99M | 2.05M | 2.08M | 2.15M | 2.03M | 2.02M | 2.03M | ||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | -2.92M | -1.03M | -1.44M | -0.41M | 4.17M | -2.07M | 2.22M | -2.73M | 1.02M | 1.53M | 0.07M | 0.03M | 0.09M | -0.51M | 3.92M | -4.13M | -0.27M | -1.49M | 8.82M | -3.94M | ||||||||
| Change in Accured ExpensesChange Accured Exp. | 4.71M | 3.80M | -2.28M | 0.56M | 3.40M | 2.84M | -10.04M | 3.79M | 2.64M | 6.79M | -15.39M | 7.80M | 2.75M | 9.02M | -11.69M | 4.75M | 0.66M | 13.66M | -7.21M | 13.49M | ||||||||
| Other Working Capital ChangesOther WC Changes | -18.76M | -15.14M | -8.36M | -9.14M | -6.67M | -13.60M | -6.14M | -12.39M | -0.95M | 10.88M | -8.26M | -23.95M | -2.42M | -6.45M | -2.10M | 28.52M | -2.76M | -2.87M | -34.37M | |||||||||
| Investing Activities | ||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.31M | 0.90M | 0.48M | 0.73M | 1.25M | 0.37M | 4.01M | 10.77M | 8.08M | 11.62M | 7.40M | 4.69M | -0.19M | 0.94M | 0.47M | 2.26M | -1.38M | 5.82M | 0.43M | -2.16M | ||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 109.29M | 96.88M | 106.46M | 147.25M | 117.67M | 97.94M | 90.43M | 99.25M | 97.76M | 76.08M | 99.50M | 124.49M | 138.07M | 147.93M | 132.74M | 118.97M | 132.44M | 103.87M | 133.86M | 135.17M | ||||||||
| Cash from Investing ActivitiesCash from Investing | -136.86M | -68.02M | 25.86M | 81.80M | -37.48M | -49.67M | 24.58M | 35.84M | 60.51M | 18.95M | -330.61M | 15.64M | -157.68M | 68.57M | 48.62M | 60.02M | -235.30M | -394.40M | -142.84M | 20.05M | ||||||||
| Financing Activities | ||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 3.26M | 1.76M | 0.45M | 0.38M | 0.96M | 1.36M | 1.49M | 0.68M | 0.13M | 0.56M | 48.74M | 0.54M | 7.70M | 4.55M | 48.83M | 19.19M | 13.38M | |||||||||||
| Cash from Financing ActivitiesCash from Financing | 246.04M | 2.05M | 0.18M | 0.36M | 150.50M | 1.95M | 1.16M | 1.30M | -0.21M | 1.93M | 353.76M | 1.41M | 250.92M | 2.77M | 0.26M | 245.73M | 39.51M | 705.22M | 18.77M | 14.42M | ||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 2.39M | 1.20M | 1.76M | 1.93M | 2.60M | 2.19M | 2.51M | 1.64M | 2.40M | 1.10M | ||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | ||||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||
| Change in Cash | 71.92M | -104.32M | -14.25M | 43.18M | 78.75M | -87.25M | -18.23M | 1.89M | 28.66M | 28.93M | -16.44M | -25.88M | 43.05M | 9.55M | -30.28M | 245.86M | -222.90M | 244.07M | -212.91M | -19.60M | ||||||||
| Free Cash FlowFCF | -37.57M | -39.25M | -40.78M | -39.72M | -35.52M | -39.91M | -47.98M | -46.02M | -39.73M | -3.58M | -46.99M | -47.62M | -50.00M | -62.72M | -79.62M | -62.14M | -25.73M | -72.57M | -89.27M | -51.90M | ||||||||
| Net Cash FlowNCF | 71.92M | -104.32M | -14.25M | 43.18M | 78.75M | -87.25M | -18.23M | 1.89M | 28.66M | 28.93M | -16.44M | -25.88M | 43.05M | 9.55M | -30.28M | 245.86M | -222.90M | 244.07M | -212.91M | -19.60M |